XML 32 R9.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS' CAPITAL - USD ($)
$ in Millions
Total
Partners’ Capital Excluding Noncontrolling Interests
Noncontrolling Interests
Limited Partners
Series A Preferred Units
Partners’ Capital Excluding Noncontrolling Interests
Limited Partners
Series B Preferred Units
Partners’ Capital Excluding Noncontrolling Interests
Limited Partners
Common Units
Partners’ Capital Excluding Noncontrolling Interests
Increase (Decrease) in Partners' Capital            
Impact of adoption of ASU 2017-05 | ASU 2017-05 $ 113         $ 113
Adjusted balance 11,071     $ 1,505 $ 788 8,778
Beginning balance excluding NCI at Dec. 31, 2017 10,958     1,505 788 8,665
Increase (Decrease) in Partners' Capital            
Net income 1,099          
Net income attributable to PAA 1,099     112 37 950
Distributions (Note 9) (802)     (112) (37) (653)
Other comprehensive income/(loss) (46)         (46)
Equity-indexed compensation expense 37         37
Other (9)       (1) (8)
Ending balance excluding NCI at Sep. 30, 2018 11,350     1,505 787 9,058
Beginning balance excluding NCI at Jun. 30, 2018 10,824     1,505 787 8,532
Increase (Decrease) in Partners' Capital            
Net income 710          
Net income attributable to PAA 710     37 12 661
Distributions (Note 9) (267)     (37) (12) (218)
Other comprehensive income/(loss) 76         76
Equity-indexed compensation expense 14         14
Other (7)         (7)
Ending balance excluding NCI at Sep. 30, 2018 11,350     1,505 787 9,058
Beginning balance at Dec. 31, 2018 12,002 $ 12,002   1,505 787 9,710
Beginning balance excluding NCI at Dec. 31, 2018 12,002          
Increase (Decrease) in Partners' Capital            
Net income 1,872 1,865 $ 7 112 37 1,716
Net income attributable to PAA 1,865          
Distributions (Note 9) (894) (890) (4) (112) (37) (741)
Other comprehensive income/(loss) 10 10       10
Equity-indexed compensation expense 13 13       13
Sale of noncontrolling interest in a subsidiary (Note 9) 128 (2) 130     (2)
Other (20) (20)       (20)
Ending balance excluding NCI at Sep. 30, 2019 12,978          
Ending balance at Sep. 30, 2019 13,111 12,978 133 1,505 787 10,686
Beginning balance at Jun. 30, 2019 13,073 12,941 132 1,505 787 10,649
Increase (Decrease) in Partners' Capital            
Net income 454 449 5 37 12 400
Net income attributable to PAA 449          
Distributions (Note 9) (315) (311) (4) (37) (12) (262)
Other comprehensive income/(loss) (99) (99)       (99)
Equity-indexed compensation expense 6 6       6
Other (8) (8)       (8)
Ending balance excluding NCI at Sep. 30, 2019 12,978          
Ending balance at Sep. 30, 2019 $ 13,111 $ 12,978 $ 133 $ 1,505 $ 787 $ 10,686